Cargando…
An optimized Factor H-Fc fusion protein against multidrug-resistant Neisseria gonorrhoeae
Novel therapeutics against the global threat of multidrug-resistant Neisseria gonorrhoeae are urgently needed. Gonococci evade killing by complement by binding factor H (FH), a key inhibitor of the alternative pathway. FH comprises 20 short consensus repeat (SCR) domains organized as a single chain....
Autores principales: | Shaughnessy, Jutamas, Chabeda, Aleyo, Tran, Y., Zheng, Bo, Nowak, Nancy, Steffens, Carolynn, DeOliveira, Rosane B., Gulati, Sunita, Lewis, Lisa A., Maclean, James, Moss, John A., Wycoff, Keith L., Ram, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468773/ https://www.ncbi.nlm.nih.gov/pubmed/36110842 http://dx.doi.org/10.3389/fimmu.2022.975676 |
Ejemplares similares
-
Development of Complement Factor H–Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant Neisseria gonorrhoeae
por: Shaughnessy, Jutamas, et al.
Publicado: (2020) -
Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine
por: Gulati, Sunita, et al.
Publicado: (2019) -
Neisseria gonorrhoeae FC428 Subclone, Vietnam, 2019–2020
por: Trinh, Trang Minh, et al.
Publicado: (2022) -
Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine
por: Gulati, Sunita, et al.
Publicado: (2019) -
Defining the Binding Region in Factor H to Develop a Therapeutic Factor H-Fc Fusion Protein against Non-Typeable Haemophilus influenzae
por: Wong, Sandy M., et al.
Publicado: (2016)